Cleancard
At‑home cancer diagnostics powered by AI for earlier detection and zero mortality.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
At‑home cancer diagnostics powered by AI for earlier detection and zero mortality.
Oncology
Technology Platform
A tri‑modal platform combining at‑home biosensors, cloud‑based health data aggregation, and AI/ML models to detect cancer biomarkers early and generate personalized risk scores.
Opportunities
Early‑detection market growth and AI‑driven risk stratification create pathways for licensing, partnership with pharma, and direct‑to‑consumer scaling.
Risk Factors
Regulatory approval timelines, data privacy concerns, and competition from established diagnostics firms could impede commercialization.
Competitive Landscape
Competes with traditional labs and emerging digital‑diagnostic startups; differentiation stems from integrated at‑home testing and proprietary AI analytics.